Mary Lopez

Dr. Lopez has over 25 years of experience in the fields of Proteomics and Mass Spectrometry and joined Nuclear Biotechnologies in 2015. +/-

She received her PhD from the University of Massachusetts Amherst and did her postdoctoral work at MIT where she received an NIH fellowship. Dr Lopez has held leadership positions in several Health related and Biotechnology companies including Millipore Corp., Perkin Elmer and most recently, Thermo Fisher Scientific. She has authored over 70 peer reviewed publications in her field, has been awarded several patents and serves on the Scientific Advisory Board of the Clinical Proteomics Research Center at Massachusetts General Hospital. Dr Lopez is also on the Board of the US Human Proteome Organization (HUPO) and is an associate editor of Clinical Proteomics.